| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |